Page 10 - Agns Arm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Agns arm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Agns Arm Today - Breaking & Trending Today

Genus (LON:GNS) Earns Hold Rating from Peel Hunt

Genus (LON:GNS – Get Rating)‘s stock had its “hold” rating restated by Peel Hunt in a note issued to investors on Tuesday, MarketBeat Ratings reports. They presently have a GBX 4,500 ($58.64) target price on the stock. Peel Hunt’s target price suggests a potential upside of 70.71% from the stock’s current price. LON GNS opened […] ....

United States , United Kingdom , Genus Research , Get Rating , Peel Hunt , Marketbeat Ratings , North America , Latin America , Middle East , Lon Gns , Reiterated Rating ,

Genus (LON:GNS) Hits New 12-Month Low at $2,800.00

Genus plc (LON:GNS – Get Rating) shares hit a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 2,800 ($36.68) and last traded at GBX 2,814 ($36.86), with a volume of 3455 shares. The stock had previously closed at GBX 2,810 ($36.81). Separately, Liberum Capital restated a “buy” […] ....

United States , United Kingdom , Genus Research , Get Rating , Liberum Capital , North America , Latin America , Middle East , Lon Gns ,

Genus (LON:GNS) Reaches New 12-Month Low at $2,818.00

Genus plc (LON:GNS – Get Rating)’s share price reached a new 52-week low during trading on Thursday . The stock traded as low as GBX 2,818 ($37.10) and last traded at GBX 2,822 ($37.15), with a volume of 29392 shares trading hands. The stock had previously closed at GBX 2,922 ($38.47). Separately, Liberum Capital reaffirmed […] ....

United States , United Kingdom , Genus Research , Agenus Company Profile , Get Rating , Liberum Capital , Company Profile , North America , Latin America , Middle East , Lon Gns ,

BETTER SLEEP Achieves Primary Endpoint Across All Patient Cohorts

BETTER SLEEP Achieves Primary Endpoint Across All Patient Cohorts  First clinical data demonstrating effectiveness of HGNS to treat CCC patients As previously disclosed, confirms. | March 14, 2022 ....

Mont Saint Guibert , Waals Gewest , Olivier Taelman , World Sleep Congress , Primary Endpoint Across All Patient , Obstructive Sleep Apnea , Complete Concentric Collapse , Chief Executive Officer , Nyxoah Sa Stock Exchange , Press Release , Reviously Nyxh Be0974358906 ,